China Cord Blood (CO) Reports In-Line Q2 EPS

China Cord Blood (NYSE: CO) reported Q2 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $27 million versus the consensus estimate of $26.42 million.

For earnings history and earnings-related data on China Cord Blood (CO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c